Research progress in influence of gut microbiota on insulin secretion and inflammatory pathways in patients with diabetic nephropathy
CSTR:
Author:
Affiliation:

(1. Medical Department of Traditional Chinese and Western Medicine, First School of Clinical Medicine, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, Shaanxi Province, China;2. Department of Nephrology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, Shaanxi Province, China)

Clc Number:

Fund Project:

This work was supported by the National Natural Science Foundation of China ( 81873296) and the Construction Project of the Third Famous Traditional Chinese Medicine (Herbalist) Inheritance Studio of Shaanxi Province (2019002)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Diabetic nephropathy (DN) has been one of the major public health problems in China, and most patients eventually develop end-stage renal disease. In the context of research in "gut-kidney axis" in recent years, increasing evidence supports the dual influence of gut microbiota and kidney. This article elaborates the effects of gut microbiota of its metabolites (short-chain fatty acids axis, bile acids axis, and endotoxin axis) on insulin secretion and inflammatory response in different DN stages, and summarizes the different pathways of gut microbiota in early and middle/late DN stages in a view to providing new research orientations for multi-target therapy of DN.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 30,2022
  • Revised:
  • Adopted:
  • Online: April 27,2023
  • Published:
Article QR Code